The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACUTUS MEDICAL INC | COM | 005111109 | 21,607 | 749,990 | SH | SOLE | 749,990 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 6,442 | 1,487,800 | SH | SOLE | 1,487,800 | 0 | 0 | ||
AKOUS INC | COM | 00973J101 | 901 | 45,459 | SH | SOLE | 45,459 | 0 | 0 | ||
AMARIN CORP PLC | SPONSORED ADR NEW | 023111206 | 1,100 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 3,504 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
AVEO BIOSCIENCES INC | COM NEW | 053588307 | 339 | 58,800 | SH | SOLE | 58,800 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HLDG | COM | G11196105 | 9,771 | 114,000 | SH | SOLE | 114,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADS | 09071M205 | 42 | 16,667 | SH | SOLE | 16,667 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 29,908 | 1,662,500 | SH | SOLE | 1,662,500 | 0 | 0 | ||
CATABASIS PHARMACEUTICALS INC | COM NEW | 14875P206 | 402 | 187,750 | SH | SOLE | 187,750 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 939 | 148,800 | SH | SOLE | 148,800 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 17,380 | 992,000 | SH | SOLE | 992,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 6,917 | 2,620,000 | SH | SOLE | 2,620,000 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 21,672 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 19,110 | 3,956,500 | SH | SOLE | 3,956,500 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 30,562 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
CONCERT PHARMACEUTICALS INC | COM | 206022105 | 3,211 | 254,000 | SH | SOLE | 254,000 | 0 | 0 | ||
CONTRAFECT CORP | COM NEW | 212326300 | 2,222 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 12,111 | 582,800 | SH | SOLE | 582,800 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 12,670 | 222,000 | SH | SOLE | 222,000 | 0 | 0 | ||
EDAP TMS SA | SPONSORED ADR | 268311107 | 3,399 | 657,500 | SH | SOLE | 657,500 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 41,520 | 315,550 | SH | SOLE | 315,550 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 3,389 | 284,050 | SH | SOLE | 284,050 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 32,845 | 4,040,000 | SH | SOLE | 4,040,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 5,452 | 147,000 | SH | SOLE | 147,000 | 0 | 0 | ||
FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 6,496 | 381,900 | SH | SOLE | 381,900 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 34960Q109 | 12,323 | 3,887,500 | SH | SOLE | 3,887,500 | 0 | 0 | ||
FS DEV CORP | COM CL A | 303020101 | 7,748 | 704,400 | SH | SOLE | 704,400 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,034 | 88,300 | SH | SOLE | 88,300 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 21,029 | 3,065,416 | SH | SOLE | 3,065,416 | 0 | 0 | ||
INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 6,724 | 3,171,800 | SH | SOLE | 3,171,800 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 8,929 | 470,203 | SH | SOLE | 470,203 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 3,696 | 708,000 | SH | SOLE | 708,000 | 0 | 0 | ||
KINIKSA PHARMACEUTICALS LTD | COM CL A | G5269C101 | 3,960 | 224,100 | SH | SOLE | 224,100 | 0 | 0 | ||
LUMOS PHARMA INC | COM | 55028X109 | 10,045 | 281,287 | SH | SOLE | 281,287 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 8,472 | 370,600 | SH | SOLE | 370,600 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 375 | 47,804 | SH | SOLE | 47,804 | 0 | 0 | ||
MEI PHARMA INC | COM NEW | 55279B202 | 4,108 | 1,556,000 | SH | SOLE | 1,556,000 | 0 | 0 | ||
MERUS NV | COM | N5749R100 | 6,188 | 353,000 | SH | SOLE | 353,000 | 0 | 0 | ||
MYOVANT SCIENCES LTD | COM | G637AM102 | 10,487 | 682,500 | SH | SOLE | 682,500 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 19,547 | 1,386,300 | SH | SOLE | 1,386,300 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 134,758 | 6,510,000 | SH | SOLE | 6,510,000 | 0 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 1,801 | 435,000 | SH | SOLE | 435,000 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES INC | COM | 74006W108 | 3,489 | 63,416 | SH | SOLE | 63,416 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 7,020 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 61,941 | 2,558,472 | SH | SOLE | 2,558,472 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 3,419 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | ||
SERES THERAPEUTICS | COM | 81750R102 | 9,804 | 335,312 | SH | SOLE | 335,312 | 0 | 0 | ||
SIERRA ONCOLOGY INC | COM NEW | 82640U404 | 1,208 | 75,379 | SH | SOLE | 75,379 | 0 | 0 | ||
SIO GENE THERAPIES INC | COM | 829399104 | 5,560 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 15,379 | 3,021,436 | SH | SOLE | 3,021,436 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | 6,995 | 322,200 | SH | SOLE | 322,200 | 0 | 0 | ||
TELA BIO INC | COM | 872381108 | 5,490 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 20,158 | 387,500 | SH | SOLE | 387,500 | 0 | 0 | ||
TRACON PHARMACEUTICALS INC | COM NEW | 89237H209 | 29,465 | 2,518,371 | SH | SOLE | 2,518,371 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 6,761 | 959,000 | SH | SOLE | 959,000 | 0 | 0 | ||
VAXCYTE | COM | 92243G108 | 8,906 | 335,200 | SH | SOLE | 335,200 | 0 | 0 | ||
VERASTEM INC | COM | 92337C104 | 4,761 | 2,325,000 | SH | SOLE | 2,325,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 20,079 | 455,000 | SH | SOLE | 455,000 | 0 | 0 |